The frequency of decrease in UACR and UPCR at 16 weeks as secondary outcomes.

Outcome Aa and Ap: frequency of decrease in UACR and UPCR ≥30% at 16 weeks, compared to baseline level. Outcome Ba and Bp: frequency of decrease in UACR and UPCR ≥50% at 16 weeks compared to baseline level, Outcome Ca and Cp: frequency of decrease in UACR and UPCR <200 mg/g cr at 16 weeks. Outcome Da and Dp: frequency of outcome B and/or C. *p<0.01, **p<0.05; difference of frequency between groups.